You have read all your free articles, to continue reading subscribe to read the rest of this content.
Novo Nordisk has entered into a definitive agreement to acquire Dicerna Pharmaceuticals (Dicerna) for a total equity value of approximately USD 3.3 billion. The acquisition of Dicerna’s ribonucleic acid interference (RNAi) platform is a strategic addition to Novo Nordisk’s existing research tAlready a subscriber Login You have read all your…
NNIT has signed an extension of its infrastructure outsourcing agreement with Novo Nordisk. The estimated total value of the agreement amounts to approximately DKK 1bn and covers global services, including support and maintenance of Novo Nordisk's corporate IT infrastructure. The agreement coversAlready a subscriber Login You have read all your…
Hansa Biopharma has announced that the European Commission has granted conditional approval for Idefirix in highly sensitized kidney transplants patients. The formal approval by the European Commission was received two months after the Committee for Medicinal Products for Human Use (CHMP) of the Already a subscriber Login You have read…
Ilya Pharma is one of ten life science companies selected this year for Springboard Enterprises’ Health Innovation Hub: Life Science. The company joins over 800 experienced “been there, run that” entrepreneurs who make up the Springboard Alumnae Network, it states in its press release. ThisAlready a subscriber Login You have…
